Superoxide dismutase 1 (SOD1) is an antioxidant enzyme that converts superoxide anion radicals into hydrogen peroxide and molecular oxygen. The senescence marker protein-30 (SMP30) is a gluconolactonase that functions as an antioxidant protein in mammals due to its involvement in ascorbic acid (AA) biosynthesis. SMP30 also participates in Ca 2+ efflux by activating the calmodulin-dependent Ca 2+ -pump. To reveal the role of oxidative stress in lipid metabolism defects occurring in non-alcoholic fatty liver disease pathogenesis, we generated SMP30/SOD1-double knockout (SMP30/SOD1-DKO) mice and investigated their survival curves, plasma and hepatic lipid profiles, amounts of hepatic oxidative stress, and hepatic protein levels expressed by genes related to lipid metabolism. While SMP30/SOD1-DKO pups had no growth retardation by 14 days of age, they did have low plasma and hepatic AA levels. Thereafter, 39% and 53% of male and female pups died by 15-24 and 89 days of age, respectively. Compared to wild type, SMP30-KO and SOD1-KO mice, by 14 days SMP30/SOD1-DKO mice exhibited: (1) higher plasma levels of triglyceride and aspartate aminotransferase; (2) severe accumulation of hepatic triglyceride and total cholesterol; (3) higher levels of superoxide anion radicals and thiobarbituric acid reactive substances in livers; and (4) decreased mRNA and protein levels of Apolipoprotein B (ApoB) in livers -ApoB is an essential component of VLDL secretion. These results suggest that high levels of oxidative stress due to concomitant deficiency of SMP30 and/or AA, and SOD1 cause abnormal plasma lipid metabolism, hepatic lipid accumulation and premature death resulting from impaired VLDL secretion.
Introduction
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of liver disease ranging from steatosis to non-alcoholic steatohepatitis (NASH), and cirrhosis [1] . In NASH, intralobular inflammation and hepatocellular ballooning are present in addition to steatosis, and are often accompanied by progressive fibrosis. Several population studies showed that NAFLD is closely associated with obesity, insulin resistance and metabolic syndrome, diabetes, and dyslipidemia. However, the pathogenesis of NAFLD/NASH has not been completely elucidated. One popular hypothesis is the ''two-hit theory'' wherein the ''first hit'' is insulin resistance that causes hepatic fat accumulation and the ''second hit'' induces hepatocyte injury and inflammation [2] . Although the mechanisms that cause hepatocyte injury in fatty liver are not fully understood, oxidative stress is a commonly proposed mechanism for hepatocellular injury.
Many antioxidant enzymes and molecules protect mammalian cells from oxidative stress caused by reactive oxygen species such as superoxide anion radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen, as well as reactive nitrogen species such as peroxynitrite [3] . Superoxide dismutase (SOD) is an antioxidant enzyme that converts superoxide anion radicals into hydrogen peroxide and molecular oxygen. SOD consists of three isozymes: copper/zinc SOD (Cu, Zn-SOD, SOD1) that localizes in the cytosol, nucleus, and mitochondrial intermembrane space, manganese SOD (Mn-SOD, SOD2), which is localized in the mitochondrial matrix, and extracellular Cu, Zn-SOD (EC-SOD, SOD3). In a previous study we reported that SOD1-knockout (KO) mice showed agerelated macular degeneration [4] , retinal degeneration [5] , skin atrophy [6] , osteoporosis [7] , deterioration of Alzheimer's disease [8] , and luteal [9] and lacrimal degeneration [10] . Other groups showed SOD1-KO phenotypes that included age-related cataracts [11] , hepatocellular carcinoma [12] , muscle atrophy [13] , and hemolytic anemia [14] .
The liver plays a key role in lipid metabolism including uptake and de novo synthesis of free fatty acids (FFA) followed by conversion of FFA into triglycerides (TG) by esterification [15] . TG are secreted into the circulation as Apolipoprotein B (ApoB)-containing very low-density lipoprotein (VLDL) or stored in hepatocytes as TG vacuoles. FFA that is not esterified into TG is metabolized by b-oxidation in the liver. VLDL transports not only endogenously synthesized lipids, in particular TG, but also some cholesterol and cholesteryl esters to peripheral tissues. ApoB100 is absolutely required for VLDL assembly and secretion. The quality of VLDL is strictly controlled in multiple steps from production to secretion by ApoB100 degradation [16] . Regarding lipid metabolism in the liver, we showed that SOD1-KO mice exhibited increased lipid peroxidation and hepatic TG accumulation due to decreases in VLDL secretion from the liver caused by oxidative degradation of ApoB. This result suggests that superoxide anion radicals may be involved in abnormal lipid metabolism in the mouse liver [17] .
We originally identified the 34 kDa senescence marker protein-30 (SMP30) in rat liver and also showed that SMP30 levels decrease with age [18, 19] . SMP30 participates in Ca 2+ efflux by promoting calmodulin-dependent Ca 2+ pump activity in HepG2 cells, which confers resistance to cell injury caused by high intracellular Ca 2+ concentrations [20] . We reported that SMP30-KO mice livers are highly susceptible to tumor necrosis factor-a-and Fas-induced apoptosis, suggesting that SMP30 has a protective role in cell injury [21] . Furthermore, SMP30-KO mice hepatocytes exhibited increased hepatic TG accumulation, total cholesterol (T-cho), and phospholipid (PL), as well as abnormally enlarged mitochondria [22] . Previously, we identified SMP30 as a gluconolactonase that catalyzes lactonization of L-gulonic acid in the penultimate step of mammalian L-ascorbic acid (AA) biosynthesis [23, 24] . AA is a free radical scavenger that acts as an electron donor and cofactor in reactions catalyzed by dopamine-b-hydroxylase and collagen prolyl-and lysyl-hydroxylase [25, 26] . In guinea pigs and primates including humans, the capacity to synthesize AA has been lost due to many mutations in the L-gulono-c-lactone oxidase gene, whereas most vertebrates can synthesize AA in vivo. We reported that AA-depleted SMP30-KO mice showed ultraviolet radiation type B-induced cataracts [27] , skin atrophy [28] , impaired catecholamine synthesis [29] , age-related hearing loss [30] , increased superoxide anion radical generation in the brain [31] , pulmonary emphysema [32] , and abnormal insulin release from pancreatic islets [33] . We also reported that SMP30 deficiency independent of AA worsens glucose tolerance by impairing acute insulin secretion [34] , causes coronary artery spasms that are triggered by chronic thiol oxidation [35] , impairs myocardium-induced dilation of coronary arterioles [36] and affects astrocyte activation, which exacerbates Parkinson's pathology [37] . In addition, SMP30-KO mice on a Lepr db/db background exhibit increases in small dense-LDL and severe fatty liver accompanied by numerous inflammatory cells and increased oxidative stress, suggesting that SMP30 is closely associated with NAFLD pathogenesis [38] .
To address the pathological role of reactive oxygen species in lipid metabolism involved in NAFLD/NASH pathogenesis, we generated SMP30/SOD1-double knockout (SMP30/SOD1-DKO) mice, and investigated oxidative stress and lipid metabolism in the livers of these mice. In this study, we show that SMP30/ SOD1-DKO mice died after 15 days without obvious growth retardation, and at 14 days of age exhibited low AA levels, high levels of plasma TG and aspartate aminotransferase (AST), and lipid accumulation in response to impaired VLDL secretion, which is caused by decreased ApoB gene expression and ApoB protein degradation that occurs in the presence of high levels of superoxide anion radicals and/or lipid peroxide. 
Results
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Sod1
À/À male mice gained weight and the body weight change was not significantly different from the other five experimental groups at 14 days of age (Fig. 1C) . While the body weight of Smp30
À/À female mice also increased, the body weight changes were significantly (16%) lower than that of Smp30
+/À animals at 14 days of age (p < 0.05).
We next determined the AA and DHA levels in the plasma and livers of Smp30
À/À male and Smp30 
+/+ mice (1.08 lmol/ g tissue), respectively. The DHA per AA plus DHA in the plasma and livers of the six experimental groups were respectively 5.9-13.7% and 2.5-3.9% in males, and 2.9-9.2% and 1.9-10.0% in females.
Smp30
Y/À
Sod1
À/À male mice show hypertriglyceridemia and liver injury
The blood biochemical parameters of 14 day old animals in the six experimental groups are presented in Table 1 . Plasma TG (135.9 ± 13.8 IU/L) were significantly higher than those of Smp30
.0 IU/L) were significantly higher than Smp30
(74.9 ± 5.0 IU/L, p < 0.001), and Smp30
The plasma alanine aminotransferase concentration was significantly higher in Smp30 
+/+ (164.1 ± 9.0 mg/dL, p < 0.05) mice. There were no significant differences in plasma insulin levels among males in the six experimental groups.
Increased hepatic lipid levels (TG and T-cho) and lipid peroxidation (TBARS) in Smp30
As shown in Fig. 2A and B, histological examination of hepatic tissues revealed increased steatosis in Smp30
À/À male and Smp30 À/À Sod1 À/À female mice at 14 days of age. In contrast, Table 1 Biochemical parameters of blood plasma in six experimetal groups of male mice. (Fig. 3B ). There were no significant differences in hepatic PL and FFA levels among the six experimental groups (Fig. 3C and  D (Fig. 5B ). There were also no differences among the six experimental groups in protein levels of MTP and Grp78, both of which are known to affect ApoB protein levels in VLDL in liver microsome fractions. 
Sod1
À/À mice (p < 0.05) (Fig. 6C) . The SREBP2 precursor was not detected in liver homogenates. Protein levels of PPARa, which is involved in fatty acid catabolism, were significantly lower in Smp30 (Fig. 6D ).
Discussion
In the present study we established SMP30/SOD1-DKO mice to assess the possible involvement of SMP30 and SOD1 in NAFLD/ NASH. SMP30/SOD1-DKO mice died at 15 days of age without obvious growth retardation, and at 14 days of age exhibited low plasma and hepatic levels of AA, higher plasma levels of TG and AST, higher hepatic TG and T-cho, lower hepatic protein levels of ApoB and PPARa, and higher superoxide anion radicals and TBARS in the liver compared with wild-type, SMP30-KO, and SOD1-KO mice. These results suggest that a concomitant deficiency of SMP30 and SOD1 causes high levels of oxidative stress in the liver that results in abnormal plasma lipid and hepatic lipid accumulation due to impaired VLDL secretion that occurs following decreased expression and protein degradation of ApoB. These defects would result in premature death.
Although antioxidant enzymes, higher SOD activity due to increased SOD1 protein levels, and decreased catalase protein levels [40] . In addition, Smp30 Y/À mice on a Lepr db/db background exhibited severe fatty liver with increased lipid peroxidation. In this study, cell injury in hepatocytes was apparent in Smp30 
Sod1
À/À mice were altered is unclear, this result suggests that SOD1 and SMP30/AA collaboratively exert protective roles against superoxide anion radicals and lipid peroxidation in vivo.
A novel finding of this study is that Smp30 
À/À mice, which also showed TG accumulation ( Fig. 3A and B) that likely results from an imbalance between TG synthesis by esterification of FFA and VLDL secretion [15] . Since we observed no alterations in hepatic FFA levels in any experimental group (Fig. 3D) , the observed hepatic TG accumulation in
Smp30
Y/À Sod1 À/À mice may have resulted from impaired VLDL secretion in the liver. We previously reported that high levels of oxidative stress enhanced impairment of VLDL secretion due to ApoB degradation in the livers of adult Sod1 À/À mice fed normal and high-fat diets [17] . We consistently observed in this study that protein levels of ApoB100 and ApoB48 were lower in the livers of lacking hepatic leptin signaling decrease hepatic Apob mRNA, and upon re-expression of functional leptin receptors in the liver, hepatic ApoB transcript levels return to wild-type levels [42] . We also reported that Smp30 Y/+ and Smp30 Y/À mice lacking hepatic leptin signaling show decreased Apob mRNA levels in the livers [38] . Although, it is uncertain whether or not hepatic leptin signaling in fatty livers of Smp30 Y/À Sod1 À/À mice is obscured, decreased ApoB transcription levels could also account for decreased protein levels of ApoB100 and ApoB48 in the liver.
Decreased VLDL secretion typically leads to low levels of plasma TG. However, compared to the other experimental groups, Smp30 Y/
À
Sod1
À/À mice showed higher plasma TG, but not TC and FFA ( Table 1 ), suggesting that uptake of TG-rich VLDL into the liver from blood might decrease in Smp30 Y/À Sod1 À/À mice. Hepatic FFA levels are determined by uptake, de novo synthesis, and b-oxidation of FFA in livers. Despite the absence of alterations in hepatic and plasma FFA levels among all experimental groups, major changes in master transcription factors involved in regulating expression of hepatic lipid metabolism genes were observed. Protein levels of PPARa, which regulates genes involved in b-oxidation of FFA, were lower in Sod1 (Fig. 6C ). In our previous study Smp30 Y/À mice showed hepatic accumulation of TG, T-cho, and PL with age [22] . Taken together, these results suggest that SMP30 deficiency and/or AA insufficiency might be relevant to cholesterol metabolism. Further studies will be required to clarify the molecular mechanism involved in the alteration of lipid homeostasis and reactive oxygen species metabolism caused by concomitant deficiency of SMP30 and/or AA, and SOD1. However, our data suggest that high levels of oxidative stress caused by defects in the antioxidant system resulted in hepatic lipid accumulation via altered lipid metabolism, predominantly decreased expression and protein degradation of ApoB, and premature death in non-obese mice, and together support that oxidative stress might be one possible cause of NAFLD.
Materials and methods
Animals and experimental protocol
Sod1
À/À mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and backcrossed with C57BL/6NCrSlc mice (Japan SLC, Inc., Shizuoka, Japan) for five to six generations. SMP30-KO mice were established and maintained as described previously [21] . The Smp30 gene is located on the X chromosome, so heterozygous SMP30-KO male mice do not exist. Because SMP30 is the penultimate enzyme in the AA biosynthetic pathway, SMP30-KO mice cannot synthesize AA in vivo [23] . To avoid any effects of AA deficiency, SMP30-KO mice were given free access to water supplemented with 1.5 g/L AA (DSM Nutrition Japan, Tokyo, Japan) and 10 lM ethylenediaminetetraacetic acid (EDTA) [39] . Sod1 , and Smp30 +/+ Sod1 À/À female mice. All mice were fed an autoclaved commercial chow diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan). Mice were maintained on a 12-h light/dark cycle in a controlled environment. All experimental procedures using laboratory animals were approved by the Animal Care and Use Committee of the Tokyo Metropolitan Institute of Gerontology (Permit Number: 12016).
Genotyping
Smp30 genotyping was performed by polymerase chain reaction using genomic DNA isolated from the tail tip as reported previously [21] . Sod1 genotypes were determined as described previously with slight modifications [17] . Polymerase chain reactions to determine both genotypes were performed under the following conditions: 1 cycle of 94°C for 3 min; 35 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 2 min; followed by 1 cycle of 72°C for 5 min. Mice were maintained on a 12-h light/dark cycle in a controlled environment.
Collection of blood and liver tissue
All mice were anesthetized at the age of 14 days. Blood was obtained from the inferior vena cava, anticoagulated with EDTA, and subsequently centrifuged at 880Âg for 15 min at 4°C. Mice were systemically perfused with ice-cold phosphate buffered saline through the hepatic portal vein to wash out any remaining blood cells. The livers were then removed and fixed with 10% neutral buffered formalin or snap frozen in Tissue-Tek Ò OCT compound (Sakura Finetek Japan Co., Ltd., Tokyo, Japan) for histological analysis, or frozen in liquid nitrogen for biochemical analysis. Frozen samples were stored at À80°C until use.
Determination of AA and DHA levels in plasma and livers
Amounts of AA and dehydroascorbic acid (DHA), an oxidized form of AA, were determined by high-performance liquid chromatography using an Atlantis dC18 5-lm column (4.6 Â 150 mm; Nihon Waters K.K., Tokyo, Japan) as described previously [43] . Plasma was mixed with equal amount of 10% metaphosphoric acid and 1 mM EDTA, and centrifuged at 21,000Âg for 15 min at 4°C. Livers were homogenized in 14 vol 5.4% metaphosphoric acid and 1 mM EDTA, and the homogenate was then centrifuged at 21,000Âg for 15 min at 4°C. To reduce DHA to AA for determination of AA plus DHA, 90 lL of supernatant was incubated with 10 lL 350 mM Tris(2-carboxyethyl)phosphine hydrochloride for 2 h at 4°C. The mobile phase was 50 mM phosphate buffer (pH 2.8), 0.2 g/L EDTA, and 2% methanol at a flow rate of 1.3 mL/min, and electrical signals were recorded using an electrochemical detector equipped with a glassy carbon electrode at +0.6 V. The value of DHA was determined by subtracting AA from AA plus DHA.
Biochemical analysis of plasma
Plasma TG, T-cho, FFA, AST, alanine aminotransferase, and glucose levels were measured by enzymatic assay kits (Wako Pure Chemicals Industries, Osaka, Japan). Plasma insulin levels were measured using an enzyme-linked immunoassay system (Ultra sensitive mouse insulin ELISA kit; Morinaga Institute of Biological Science Inc., Kanagawa, Japan).
Histological examination of liver
To evaluate histological changes, fixed liver sections (3 lm)
were subjected to hematoxylin-eosin staining. For lipid staining, frozen sections (10 lm) were prepared on glass slides (New Silane II, Muto Pure Chemicals Col, Ltd., Tokyo, Japan), stained with oil red O, washed with 60% 2-propanol, and counterstained with hematoxylin.
Measurement of T-cho, TG, PL, and FFA in the liver
Liver tissues were homogenized with 2 vol water using a handy homogenizer (Moji-mojikun; Nippon Genetics Co., Ltd., Tokyo, Japan). Homogenates were added to a chloroform-methanol (2:1; v/v) mixture, incubated for 60 min at 37°C, and centrifuged at 21,000Âg for 10 min at 4°C. The supernatant organic phase was then collected, dried under nitrogen gas and resolubilized in 2-propanol. TG, T-cho, PL, and FFA concentrations in total lipid extracts were determined using commercial enzymatic kits (Wako Pure Chemical Industries, Ltd., Osaka, Japan)
Thiobarbituric acid reactive substances (TBARS) assay
Lipid peroxidation was estimated by the amounts of TBARS in the liver that were determined according to the method of Ohkawa et al. [44] . The livers were first homogenized in 10 vol ice-cold 0.1% sodium dodecyl sulfate (SDS) using a handy homogenizer and a sonicator. The homogenates were then centrifuged at 21,000Âg for 15 min at 4°C and the supernatant was used for further assays. v/v) were added, and then the mixture was centrifuged at 21,000Âg for 5 min at 4°C. The organic phase supernatant fluorescence was measured using a SPECTRAmax Gemini (Life Technologies Corp., Carlsbad, CA, USA) with an excitation and emission wavelength set of 515 nm and 553 nm, respectively. The TBARS levels are expressed as the equivalent amounts of malondialdehyde produced from 1,1,3,3-tetraethoxypropane.
Dihydroethidium (DHE) fluorescence of liver tissue
DHE (Wako Pure Chemical Industries, Ltd.), an oxidative fluorescent dye, was used to detect superoxide anion radicals in frozen liver tissue as described previously [45] . Frozen sections (20 lm) were placed on glass slides and incubated with 5 lM DHE at 37°C for 30 min in a light-protected chamber. Images were obtained using a fluorescence microscope (IX70; Olympus Corp., Tokyo, Japan) with a wideband filter cube (U-MWIG; Olympus Corp.) at excitation and emission wavelengths of 488 nm and 590 nm, respectively.
Western blot analysis
We used liver microsome fractions for Western blot analysis of Apo B100, ApoB48, microsomal triglyceride transfer protein (MTP), and glucose-regulated protein 78 kDa (Grp78) as described previously [17] . Briefly, livers were homogenized using a Potter-type Teflon homogenizer (model TH-M; Takashima, Tokyo, Japan) in 20 vol of ice cold 20 mM Tris-HCl, pH 7.4, 0.25 M sucrose, and a protease inhibitor cocktail (cOmplete, EDTA-free; Roche Diagnostics GmbH, Mannheim, Germany). Homogenates were centrifuged at 8000Âg for 10 min at 4°C, and the supernatant was further centrifuged at 100,000Âg for 60 min at 4°C. The pellets were suspended in the same buffer. Equal amounts (55 lg for ApoB100 and ApoB48, and 10 lg for MTP and Grp78) of total protein were subjected to 3-8% Tris-acetate gel electrophoresis for ApoB100 and ApoB48 or 7.5% SDS-PAGE for MTP and Grp78, and then electroblotted onto polyvinylidene difluoride membranes, which were then blocked with Block Ace (DS Pharma Biomedical Co., Ltd., Osaka, Japan). The primary antibodies used were: anti-mouse ApoB100 goat polyclonal antibody (1:500; H-15; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-human ApoB48 goat polyclonal antibody (1:500; S-18; Santa Cruz Biotechnology), anti-mouse MTP mouse monoclonal antibody (1:2500; 612022; BD Biosciences, San Jose, CA, USA), and anti-human Grp78 mouse monoclonal antibody (1:1000; 610978; BD Biosciences). Immunoreactive ApoB100, ApoB48 and Grp78 were visualized with SuperSignal Ò West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific Inc., Waltham, MA, USA) and a LAS-3000 imaging system (GE Healthcare Japan, Tokyo, Japan). Immunoreactive MTP was visualized with ECL (GE Healthcare Japan) and LAS-3000.
Western blot analysis of sterol regulatory element binding protein (SREBP)-1, SREBP2, and peroxisome proliferator-activated receptor-a (PPARa) was performed with liver homogenates. Livers were homogenized in ice cold homogenization buffer (50 mM TrisHCl (pH 7.6), 150 mM NaCl, 0.1% SDS, and a protease inhibitor cocktail (cOmplete, EDTA-free) for 30 s using a high speed homogenizer (POLYTRON Ò PT-MR 2100; Kinematica AG, Switzerland). The homogenate was then centrifuged at 21,000Âg for 10 min at 4°C. The supernatants were boiled for 5 min with a lysis buffer containing 0.125 M Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, and 0.2% bromophenol blue at a ratio of 1:1.
Total protein (6 lg) equivalents for each sample were separated on a 5-20% polyacrylamide gel and transferred to a polyvinylidene difluoride membrane. The membranes were blocked in Block Ace before incubation with the primary antibody, followed by incubation with a horseradish peroxidase-linked goat anti-mouse IgG (1:5000; Bio-Rad Laboratories, Inc., Hercules, CA, USA) or a horseradish peroxidase-linked goat anti-rabbit IgG (1:5000; Bio-Rad Laboratories, Inc.). The primary antibodies used were: anti-SREBP1 mouse monoclonal antibody (1:500, #MS-1207-P1ABX; Thermo Fisher Scientific Inc.), anti-rat SREBP2 rabbit polyclonal antibody (1:500; NB100-74543; Novus Biologicals, LLC, Littleton, CO, USA), and anti-human PPARa rabbit polyclonal antibody (1:500; sc-9000; Santa Cruz Biotechnology). After washing, the immunoreactivity of SREBP1 and SREBP2 was detected using SuperSignal Ò West Dura Extended Duration Substrate (Thermo Fisher Scientific Inc.) and LAS-3000. Immunoreactive PPARa was visualized with SuperSignal Ò West Femto Maximum Sensitivity Substrate and LAS-3000. Chemiluminescence signals were quantified with Multi Gauge ver.3.0 software (GE Healthcare Japan). The mean signals from five Smp30 Y/+ Sod1 +/+ mice were assigned a relative value of 1.0.
4.11. RNA isolation, first-strand cDNA synthesis, and quantitative realtime polymerase chain reaction (qPCR)
Liver tissue was homogenized in ice-cold ISOGEN reagent (Nippon Gene Co., Ltd., Tokyo, Japan) with a handy homogenizer before isolation of total RNA according to the manufacturer's instructions. RNA concentrations were determined and confirmed as free from protein contamination by measuring absorbance at 260 and 280 nm. Total RNA (2.5 lg) was reverse-transcribed using GAC TCC TCC TTC TTC  TCA TCT TTC-3 0 , 5 0 -GTC ATC GCT CAG GGT GTT G-3 0 , and 5 0 -/56-FAM/CTG TGG CTG/ZEN/TTT CTG CTG CCC/3IABkFQ/-3 0 for Rplp2, ribosomal protein, large P2 (NM_026020). The reactions were performed by using the StepOnePlus™ Real-Time PCR System (Life Technologies Corp.). The product specificity generated for each primer set was examined for gel electrophoresis. The relative expression levels of Apob were normalized to Rplp2 using relative standard method. Signals from Smp30 Y/+ Sod1 +/+ mice were assigned a relative value of 1.0. Five animals from each group were examined, and qPCR was run in duplicate for each sample.
Determination of protein concentration
The protein concentration was determined by the bicinchoninic acid protein assay using bovine serum albumin as a standard [46] .
Statistical analysis
The values are expressed as means ± SEM. Statistical analyses were performed with KaleidaGraph software (Synergy Software Inc., Reading, PA, USA). The significance of differences among the groups was determined by analysis of variance and Turkey's honestly significant difference test. Survival analysis was conducted by Kaplan-Meier curves and log-rank tests using IBM SPSS Statistics 20 (IBM Japan, Tokyo, Japan). Differences were considered significant at p < 0.05.
